This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Arzneimittelwerk Dresden Gmbh. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Joachim Wolf: Innovator in Controlled Release Compositions
Introduction
Joachim Wolf is a notable inventor based in Radebeul, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions. His innovative approach has led to the creation of a patented process that enhances the delivery of pharmaceutically active ingredients.
Latest Patents
Wolf holds a patent for a "Process for preparing a controlled release composition." This process involves granulating the active ingredient with a molten matrix material at an elevated temperature, followed by cooling and screening the granulate. The method also includes forming a fluidized bed of the resulting material and recovering the final product. This patent represents a significant advancement in the formulation of controlled release medications.
Career Highlights
Throughout his career, Joachim Wolf has worked with prominent companies in the pharmaceutical industry. He has been associated with Arzneimittelwerk Dresden GmbH and Teva GmbH, where he has applied his expertise in drug formulation and development. His work has contributed to the advancement of pharmaceutical technologies and improved patient outcomes.
Collaborations
Wolf has collaborated with several professionals in his field, including Torsten Hoffmann and Klaus Liebold. These collaborations have fostered innovation and have been instrumental in the development of new pharmaceutical processes.
Conclusion
Joachim Wolf's contributions to the field of controlled release compositions highlight his role as an influential inventor. His patented process and collaborations with industry professionals underscore his commitment to advancing pharmaceutical technology. His work continues to impact the way medications are formulated and delivered to patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile